SCI & TECH● LOWAug 14 · Aug 14, 2026, 12:28 AM
CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission
Seeking Alpha Tech
CapsoVision expects FDA clearance for its AI Highlights technology by the end of Q3 and plans to submit CapsoCam Colon for approval in Q4. This indicates progress in the development and regulatory pathway for new medical imaging technologies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH25m agoKenyans did college student homework for years . Then AI arrivedbusiness-standard.com · IndiaSCI & TECH1h agoSocial algorithm opt - out locked in under legal overhaulmaitlandmercury.com.au · AustraliaSCI & TECH2h agoUBS demands new junior bankers show proficiency in AIFinancial TimesSCI & TECH2h agoSocial algorithm opt - out locked in under legal overhaulbunburymail.com.au · Australia